Onkologische Schwerpunktpraxis Speyer

Speyer 5 trials

5 Registered trials

0 Currently recruiting

Organisation

Onkologische Schwerpunktpraxis Speyer

Location

Speyer, Germany

Identifier

ORL-000002835

Address

Hilgardstrasse 30, 67346, Germany

Departments

Hämatologie und Onkologie
Onkologische Praxis Speyer
Onkologische Schwerpunktpraxis Speyer
Onkologischen Schwerpunktpraxis

Clinical trials at this site (5)

Search interface

Sacituzumab Govitecan in primary HER2-negative breast cancer (SASCIA) Ended

2023-510390-33-00 HER2-negative breast cancer patients with high relapse 5 2020-10-23
FOLFOX before surgey compared to risk-adapted chemotherapy after surgery in patients with locally advanced rectal cancer and low risk for lo… Ended

2024-518077-34-00 locally advanced rectal cancer 5 2020-09-30
A randomized phase III trial assessing the benefit of the addition of isatuximab to lenalidomide / bortezomib / dexamethasone (RVd) inductio… Ended

2024-513464-26-00 Multiple Myeloma 5 2018-10-18
A randomized phase III non-inferiority trial assessing lenalidomide, bortezomib and dexame-thasone induction therapy with either intravenous… Ended

2024-516300-41-00 Multiple Myeloma 5 2023-03-07
CIRCULATE Ended

2023-506715-18-00 colon cancer stage II, rectal cancer stage II 5 2019-12-04